USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: MYOMICS, INC.
City: PROVIDENCE
State: RI
Zip+4: 02904 2615
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $298,039.00 3
SBIR Phase II $1,491,944.00 2
STTR Phase I $99,939.00 1

Award List:

SBIR Phase I: Physiologic High Throughput Screening of Bioengineered Tissues

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: NSF
Principal Investigator: Herman Vandenburgh, Dr
Award Amount: $99,991.00
Abstract:
The Small Business Innovation Research (SBIR) Phase I project will develop an innovative high-throughput/ high content drug screening platform utilizing three-dimensional human skeletal muscle tissue constructs which mimic in vivo skeletal muscle to quantify muscle force generation. The proposed… More

Electro-Mechanical Micro-Post Array to Detect In Vitro Muscle Contraction

Award Year / Program / Phase: 2006 / STTR / Phase I
Agency: HHS
Research Institution: MIRIAM HOSPITAL
Principal Investigator: Herman H. Vandenburgh
Award Amount: $99,939.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Myomics? technology to be developed in this Phase 1 project is based upon an in vitro skeletal muscle tissue force measurement technique for high throughput screening (HTS) of compounds to attenuate muscle weakness. The technology, termed Patterned… More

High Content Screening for Muscular Dystrophy

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Herman H. Vandenburgh
Award Amount: $99,912.00
Abstract:
DESCRIPTION (provided by applicant): Myomics' drug screening technology to be developed in this Phase 1 SBIR project for Duchene muscular dystrophy (DMD) is based upon an in vitro skeletal muscle tissue force measurement technique for high content screenin g (HCS) of compounds to attenuate muscle… More

SBIR Phase II: Physiologic High Throughput Screening of Bioengineered Tissues

Award Year / Program / Phase: 2007 / SBIR / Phase II
Agency: NSF
Principal Investigator: Herman D. Vandenburgh, PhD
Award Amount: $499,956.00
Abstract:
This Small Business Innovation Research (SBIR) Phase II research develops an innovative high-throughput/high content drug screening platform that utilizes three-dimensional human skeletal muscle tissue constructs that mimic in vivo skeletal muscle to quantify muscle force generation. Significant… More

High Content Drug Screening with Cardiac Tissue

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: Herman H. Vandenburgh
Award Amount: $98,136.00
Abstract:
DESCRIPTION (provided by applicant): Myomics, Inc. has developed High Content Drug Screening (HCS) technology for in vitro testing of compounds which alter contractile forces generated by miniaturized tissue engineered organs (Myo-Force Assay SystemTM, MFA STM). Myomics' 3-D tissue/force sensor… More

High Content Screening for Muscular Dystrophy

Award Year / Program / Phase: 2009 / SBIR / Phase II
Agency: HHS
Principal Investigator: Herman H. Vandenburgh
Award Amount: $991,988.00
Abstract:
DESCRIPTION (provided by applicant): Duchenne Muscular Dystrophic (DMD) is a fatal genetic disease affecting tens of thousands of boys in the U.S. There is currently no cure for the disease and few drugs are available to slow the progressive loss in skele tal muscle strength. Glucocorticoids such… More